Table 4.
Authors | n | GW at testing | Test | Outcome (GW) | Sen. (%) | Spec. (%) | PPD (%) | NPD (%) |
---|---|---|---|---|---|---|---|---|
Fukami et al. [58] | 3030 | 16–19 | Absence CGA | 22–31 | 75.0 | 99.8 | 54.5 | 99.9 |
CL ≤ 30 mm + Absence CGA | 22–31 | 50.0 | 99.8 | 40.0 | 99.9 | |||
Absence CGA | 32–36 | 2.3 | 99.7 | 18.2 | 97.2 | |||
CL ≤ 30 mm + Absence CGA | 32–36 | 2.3 | 99.7 | 20.0 | 97.2 | |||
| ||||||||
Pires et al. [59] | 338 | 21–24 | Absence CGA | <35 | 54.5 | 99.1 | 66.7 | 98.5 |
Absence CGA | <37 | 38.1 | 9.7 | 88.9 | 96.0 |